“Assessment of an EMR-integrated Onco-Insight hospital-based cancer registry system for data completeness and data entry turnaround time at a tertiary care cancer center in India” - Report - MDSpire

“Assessment of an EMR-integrated Onco-Insight hospital-based cancer registry system for data completeness and data entry turnaround time at a tertiary care cancer center in India”

  • By

  • Amey Oak

  • Sandhya Cheulkar

  • Sivaranjini K.

  • Riya John

  • Meghaj Jadhav

  • Dhanvi Patil

  • Esha Dashmukhe

  • Ashwini Patil

  • Sachin Wankhade

  • Pragati Gode

  • Aijimol Thakadiyil

  • Ganesh Balasubramanium

  • Gauravi Mishra

  • Rajesh Dikshit

  • Pankaj Chaturvedi

  • Sudeep Gupta

  • June 9, 2026

  • 0 min

Share

Evaluation of a Hospital-Based Cancer Registry System Integrated with EMR

Overview

{'metrics': {'data_completeness': 'Specify the percentage increase in data completeness.', 'abstraction_time': 'Provide the percentage reduction in abstraction time.'}}

Background

{'statistics': 'Include specific references or data points regarding cancer incidence and mortality in India.'}

Data Highlights

Variable TypeRetrieved CasesProportion
Sociodemographic32,35997.59%
Diagnostic13,98743.22%
Treatment16,83550%

Key Findings

{'context': 'Explain the implications of the mean abstraction time reduction on overall registry efficiency.'}

Clinical Implications

{'details': 'Discuss how enhanced data completeness can lead to improved patient outcomes.'}

Conclusion

{'future_research': 'Identify specific areas for further study or technological advancement.'}

Related Resources & Content

  1. The ASCO Post, 2026 -- Study Shows Potential Missing Patient Information in SEER Database
  2. Clinical Research in Cardiology -- Evaluation of Coronary Artery Disease in Patients Admitted for Cancer Therapy
  3. Drugs - Real World Outcomes -- Exploratory Research on Gathering Patient-Reported Adverse Event Information Through an Electronic System in a Cancer Clinical Trial Setting
  4. ICMR-NCDIR HBCR Procedure Manual 2025
  5. IARC Guidance on Cancer Registries
  6. Assessment of the Reliability of Swedish Data Collected in the International Enhanced Recovery After Surgery (ERAS) Database
  7. Advancing Electronic Reporting | NPCR | CDC
  8. 9th Edition of the UICC TNM Classification of Malignant Tumours
  9. https://hbcr.ncdirindia.org/HBCR_Master/assets/Pdf/Procedure_manual_2025.pdf
  10. https://publications.iarc.who.int/_publications/media/download/6625/3132fcebee4121af1f3395ad2ddbd94d3b4446c2.pdf
  11. Metastatic presentation of breast cancer in India: evidence from national cancer registry (2009–2020) - PMC
  12. Call for Data
  13. XML Data Exchange Standard
  14. Edit Sets: What They Are, How They Are Used, and What's New for v25A - The NAACCR Narrative
  15. SEER Program Coding and Staging Manual 2026 Effect
  16. Home - minimal Common Oncology Data Elements (mCODE) Implementation Guide v4.0.0
  17. Real-time data in cancer registries: Validation of an automated data extraction system - ScienceDirect
  18. Using natural language processing to extract information from clinical text in electronic medical records for populating clinical registries: a systematic review - PMC
  19. A Scalable Method for Validated Data Extraction from Electronic Health Records with Large Language Models | medRxiv
  20. Performance evaluation of an AI-powered system for clinical trial eligibility using mCODE data standards. | Journal of Clinical Oncology
  21. Using machine learning to link electronic health records in cancer registries: On the tradeoff between linkage quality and manual effort - ScienceDirect

Original Source(s)

“Assessment of an EMR-integrated Onco-Insight hospital-based cancer registry system for data completeness and data entry turnaround time at a tertiary care cancer center in India”

  • by Amey Oak, Sandhya Cheulkar, Sivaranjini K., Riya John, Meghaj Jadhav, Dhanvi Patil, Esha Dashmukhe, Ashwini Patil, Sachin Wankhade, Pragati Gode, Aijimol Thakadiyil, Ganesh Balasubramanium, Gauravi Mishra, Rajesh Dikshit, Pankaj Chaturvedi, Sudeep Gupta

  • June 9, 2026

Related Content

D-VRD induction and autologous transplant in patients ≥70 years

Neurofilament light and glial fibrillary acidic protein do not reflect neuronal or glial damage during different intracranial radiotherapy regimes: a pilot study

Tislelizumab combined with gemcitabine as first-line treatment in cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma: a single center, single-arm phase 2 trial